CME Group Inc. (CME) Stock
NASDAQCME has an Alpha Score of 61 out of 100 (moderate), computed on Oct 28, 2026 from 4 of 4 sub-scores. 24 members of Congress disclosed 55 trades in CME since 2014: 28 purchases and 27 sales, most recently Gilbert Cisneros (partial sale, Jun 16, 2026). 9 of the hedge funds AlphaScala tracks reported CME in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Marshall Wace's at $494.95M. Company insiders reported 1 open-market buy and 5 sales on SEC Form 4 in the 90 days to Oct 30, 2026. Its trailing P/E ratio is 24.9 and its net margin 34.0% (key statistics as of Oct 22, 2026).
What is CME's Alpha Score?
How it works →Alpha Score of 61 reflects moderate overall profile with strong momentum, weak value, strong quality, moderate sentiment.
Computed Oct 28, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded CME Group Inc. (CME)?
Most recent: Gilbert Cisneros (partial sale, Jun 16, 2026); records start Mar 13, 2014.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Gil Cisneros D-CA · House | 2026-06-16 | partial sale | $1k – $15k |
| Alan Armstrong R-OK · Senate | 2026-03-27 | purchase | $1k – $15k |
| Gil Cisneros D-CA · House | 2026-01-09 | purchase | $1k – $15k |
| Julie Johnson D-TX · House | 2025-12-18 | sale | $1k – $15k |
| Julie Johnson D-TX · House | 2025-11-13 | partial sale | $1k – $15k |
| Val Hoyle D-OR · House | 2025-09-23 | sale | $1k – $15k |
| Julie Johnson D-TX · House | 2025-08-14 | partial sale | $1k – $15k |
| Julie Johnson D-TX · House | 2025-08-11 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Oct 29, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
Every member of Congress who traded CME, with filing lags →Which hedge funds own CME?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Marshall Wace | 2.24M | $494.95M | +179% |
| Citadel Ken Griffin | 1.51M | $332.44M | +303% |
| D.E. Shaw David Shaw | 1.32M | $292.16M | +860% |
| Millennium Management Israel Englander | 1.20M | $264.11M | +612% |
| Point72 Steve Cohen | 744K | $164.22M | +726% |
| Renaissance Technologies Jim Simons (founder) | 680K | $150.18M | +1854% |
| Baupost Group Seth Klarman | 619K | $136.69M | NEW |
| Viking Global Investors Andreas Halvorsen | 153K | $33.78M | NEW |
| Soros Fund Management George Soros (founder) | 30K | $6.63M | n/a |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are CME Group Inc. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Oct 27, 26 | Cutinho Sunil | Chief Information Officer | SELL | 5.0K | $1.5M |
| Oct 22, 26 | Gepsman Martin J | Director | SELL | 400 | $121K |
| Sep 25, 26 | Shepard William R | Director | BUY | 292.55 | $79K |
| Sep 14, 26 | Cook Elizabeth A | Director | SELL | 500 | $140K |
| Sep 10, 26 | Duffy Terrence A | Chairman and CEO | SELL | 14.4K | $3.9M |
| Sep 10, 26 | Duffy Terrence A | Chairman and CEO | SELL | 628 | $173K |
| Mar 26, 26 | Shepard William R | Director | BUY | 1.4K | $419K |
| Mar 26, 26 | Shepard William R | Director | BUY | 62.06 | $18K |
| Mar 17, 26 | Marcus Jonathan L | Sr MD General Counsel | SELL | 3.3K | $1.0M |
| Mar 17, 26 | Marcus Jonathan L | Sr MD General Counsel | SELL | 3.3K | $1.1M |
SEC Form 4 filings as of Oct 30, 2026
See cluster-buy signals across all tickers →What are CME's key statistics?
Key statistics as of Oct 22, 2026
How does CME's valuation compare with the Financials sector?
| Metric | CME | Financials median | Companies in median |
|---|---|---|---|
| P/E ratio | 24.9 | 13.4 | 191 |
| Net margin | 33.99% | 20.01% | 181 |
| Return on equity | 15.58% | 12.63% | 202 |
| Dividend yield (payers) | 2.03% | 3.28% | 153 |
Medians over the Financials stocks whose key statistics were refreshed in the last 35 days (newest Nov 1, 2026). P/E excludes loss-making companies.
AlphaScala analysis on CME
Latest 5CME price chart
Powered by TradingViewWhat does CME Group Inc. do?
CME Group Inc. operates the world's leading and most diverse derivatives marketplace, facilitating the trading of futures and options contracts across major asset classes. It offers products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, metals, and additional categories like weather and real estate, enabling market participants to manage risk effectively. Through its principal brands—Chicago Mercantile Exchange (CME), Chicago Board of Trade (CBOT), and New York Mercantile Exchange (NYMEX)—the company provides clearing and settlement services via CME Clearing, ensuring transaction safety as the central counterparty. Key services include clearing and transaction fees, listing services, market data provision, and risk mitigation tools. CME Group supports professional traders, financial institutions, corporations, producers, governments, and central banks with electronic trading on the CME Globex platform, delivering high liquidity, speed, and global access. Founded in 1898 and headquartered in Chicago, Illinois, CME Group Inc. plays a pivotal role in establishing benchmark prices and enhancing market integrity worldwide.